Impact of social-psychiatric services and psychiatric clinics on involuntary admissions

  • Declaration of conflicting interest G.J. received fees for consulting from AstraZeneca, Bristol-Myers-Squibb/Otsuka, Janssen, Lilly, Lundbeck and Pfizer. He
    was advisory board member of AstraZeneca, Bristol-Myers-Squibb/Otsuka and Janssen-Cilag. He received research funding from
    Jansen, AstraZeneca, Lundbeck and BMS. All other authors declare that there is no conflict of interest.

  • Comments Off on Impact of social-psychiatric services and psychiatric clinics on involuntary admissions

    Tags: ,

    UA-25380860-1